Search results for "Alzheimer's"

showing 10 items of 308 documents

Increased blood mercury levels in patients with Alzheimer's disease.

1998

Alzheimer's disease (AD) is a common neurodegenerative disorder that leads to dementia and death. In addition to several genetic parameters, various environmental factors may influence the risk of getting AD. In order to test whether blood levels of the heavy metal mercury are increased in AD, we measured blood mercury concentrations in AD patients (n = 33), and compared them to age-matched control patients with major depression (MD) (n = 45), as well as to an additional control group of patients with various non-psychiatric disorders (n = 65). Blood mercury levels were more than two-fold higher in AD patients as compared to both control groups (p = 0.0005, and p = 0.0000, respectively). In…

Malemedicine.medical_specialtyPathologyNeurologychemistry.chemical_elementtau ProteinsCentral nervous system diseaseDegenerative diseaseAlzheimer DiseaseInternal medicineBlood plasmamedicineDementiaHumansBiological PsychiatryAgedAged 80 and overDepressive DisorderAmyloid beta-PeptidesNeurodegenerationMercuryMiddle Agedmedicine.diseaseMercury (element)Psychiatry and Mental healthEndocrinologyNeurologychemistryLinear ModelsFemaleNeurology (clinical)Alzheimer's diseasePsychologyBiomarkersJournal of neural transmission (Vienna, Austria : 1996)
researchProduct

CSF APPsα and Phosphorylated Tau Protein Levels in Mild Cognitive Impairment and Dementia of Alzheimer's Type

2008

We exploratively measured APPs alpha, a secreted fragment of the non-amyloidogenic cleavage of amyloid precursor protein via a-secretase, and tau protein phosphorylated at threonine 181 (p tau) in the cerebrospinal fluid of 10 patients with mild cognitive impairment, 20 patients with dementia of Alzheimer's type, and 10 controls. Cerebrospinal fluid APPs alpha and p tau levels were correlated with cognitive performance. P tau levels were significantly elevated in mild cognitive impairment and in patients with dementia of Alzheimer's type, APPs alpha levels were significantly reduced in patients with dementia of Alzheimer's type compared to the controls. APPs alpha levels were associated wit…

Malemedicine.medical_specialtyPathologyTau proteintau ProteinsNeuropsychological TestsSeverity of Illness IndexCerebrospinal fluidDegenerative diseaseAlzheimer DiseaseInternal medicineTask Performance and AnalysismedicineAmyloid precursor proteinHumansDementiaSex DistributionThreonineAgedAnalysis of VariancebiologyChemistrymedicine.diseasePsychiatry and Mental healthMemory Short-TermEndocrinologyMental Recallbiology.proteinPhosphorylationFemaleNeurology (clinical)Amyloid Precursor Protein SecretasesGeriatrics and GerontologyAlzheimer's diseaseCognition DisordersBiomarkersJournal of Geriatric Psychiatry and Neurology
researchProduct

Associations of neuropsychiatric symptoms and antidepressant prescription with survival in Alzheimer's disease

2017

Objective Depression is associated with increased mortality in community samples. The use of antidepressant medication may also increase mortality, however, it is still unclear whether taking antidepressants before or after a diagnosis of dementia influences survival. Design Retrospective. Setting A cohort with a diagnosis of Alzheimer disease (AD) from a large mental health and dementia care database in South London, linked to hospitalization and mortality data. Participants Mild dementia (Mini-Mental State Examination ≥18/30) at the point of diagnosis. Measurements We ascertained antidepressant prescription, either in the 6 months before or after dementia diagnosis, and used the HoNOS65+,…

Malemedicine.medical_specialtyPediatricsDatabases FactualDementia; antidepressants; depression; mortalityKaplan-Meier EstimateNeuropsychological TestsRisk AssessmentSeverity of Illness Index03 medical and health sciencesSex Factors0302 clinical medicineAlzheimer DiseasemedicineHumansDementia030212 general & internal medicineMedical prescriptionRisk factorPsychiatryGeneral NursingDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective StudiesAged 80 and overDepressive Disorderbusiness.industryHealth PolicyHazard ratioAge FactorsGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysismortalityAntidepressive AgentsConfidence intervalantidepressantsdepressionCohortFemaleDementiaGeriatrics and GerontologyAlzheimer's diseasebusinessdementia mortality030217 neurology & neurosurgery
researchProduct

Circadian System Functionality, Hippocampal Oxidative Stress, and Spatial Memory in the APPswe/PS1dE9 Transgenic Model of Alzheimer Disease: Effects …

2012

Alzheimer disease (AD) is a neurodegenerative disorder that primarily causes β-amyloid accumulation in the brain, resulting in cognitive and behavioral deficits. AD patients, however, also suffer from severe circadian rhythm disruptions, and the underlying causes are still not fully known. Patients with AD show reduced systemic melatonin levels. This may contribute to their symptoms, since melatonin is an effective chronobiotic and antioxidant with neuroprotective properties. Here, the authors critically assessed the effects of long-term melatonin treatment on circadian system function, hippocampal oxidative stress, and spatial memory performance in the APPswe/PS1 double transgenic (Tg) mou…

Malemedicine.medical_specialtyPhysiologyChronobioticRamelteonReceptors MelatoninHippocampusMice TransgenicMotor Activitymedicine.disease_causeHippocampusNeuroprotectionBody TemperatureMelatoninAmyloid beta-Protein PrecursorMiceAlzheimer DiseaseMemoryPhysiology (medical)Internal medicinePresenilin-1medicineAnimalsCircadian rhythmMelatoninmedicine.diseaseCircadian RhythmDisease Models AnimalOxidative StressEndocrinologyIndenesMutant ProteinsAlzheimer's diseasePsychologyNeuroscienceOxidative stressmedicine.drugChronobiology International
researchProduct

Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis

2016

We conducted a systematic review and meta-analysis investigating the influence of acetylcholinesterase inhibitors (AChEIs) therapy on nutritional status and weight across observational and interventional studies. Two authors searched major electronic databases from inception until 10/14/2015 for longitudinal, open-label and randomised double-blind placebo controlled (randomised controlled trials (RCTs)) studies of AChEIs in patients with dementia reporting nutritional status outcome data. Out of 3551 initial hits, 25 studies (12 open-label trials, 9 RCTs and 4 longitudinal studies) including 10 792 patients with dementia were meta-analysed. In longitudinal studies (median follow-up 6 months…

Malemedicine.medical_specialtyPlaceboRisk Assessment03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Weight lossAlzheimer DiseaseInternal medicineWeight LossmedicineDementiaHumansCumulative incidence030212 general & internal medicineAgedRandomized Controlled Trials as TopicGeriatricsbusiness.industryDEMENTIAmedicine.diseaseMETA-ANALYSISALZHEIMER'S DISEASE; DEMENTIA; GERIATRICS; META-ANALYSIS; Neurology (clinical); Psychiatry and Mental Health; Surgery; Arts and Humanities (miscellaneous)Acetylcholinesterase inhibitorsALZHEIMER'S DISEASEPsychiatry and Mental HealthMeta-analysisPhysical therapyObservational studyFemaleSurgeryCholinesterase InhibitorsNeurology (clinical)medicine.symptombusinessOlder peopleGERIATRICS030217 neurology & neurosurgery
researchProduct

Assessment of brain core temperature using MR DWI-thermometry in Alzheimer disease patients compared to healthy subjects

2017

Purpose: To assess the brain core temperature of Alzheimer disease (AD) patients in comparison with healthy volunteers using diffusion-weighted thermometry. Materials and methods: Fourteen AD patients (3 men, 11 women; age range 60–81 years, mean age 73.8 ± 6.1 years) and 14 healthy volunteers, age and sex-matched (mean age 70.1 ± 6.9 years; range 62–84 years; 5 men, 9 women) underwent MR examination between February 2014 and March 2016. MR imaging studies were performed with a 1.5-T MR scanner. Brain core temperature (T: °C) was calculated using the following equation from the diffusion coefficient (D) in the lateral ventricular (LV) cerebrospinal fluid: T = 2256.74/ln (4.39221/D) − 273.15…

Malemedicine.medical_specialtyThermometryCore temperatureBody Temperature030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineCerebrospinal fluidAlzheimer DiseaseHumansMedicineRadiology Nuclear Medicine and imagingStatistical analysisAgedRetrospective StudiesAged 80 and overbusiness.industryDiffusion-weighted imaging temperatureSignificant differenceHealthy subjectsBrainMean ageMiddle Agedmedicine.diseaseMr imagingDiffusion Magnetic Resonance ImagingCase-Control StudiesFemaleDiffusion-weighted imagingRadiologyAlzheimer's diseasebusinessNuclear medicine030217 neurology & neurosurgeryMRIJapanese Journal of Radiology
researchProduct

Effect of Repetition and Inspection Times on Picture Recall in Patients with Dementia of Alzheimer Type

1997

The present study is part of a series of systematic studies intended to identify simple strategies of picture presentation to improve recall performance in demented subjects. The aims of this design were to examine the effects of elaboration by naming, 4-fold repetition and different inspection times on memory performance. 19 patients with senile dementia of Alzheimer type and 21 control subjects with remitted depression were included. Picture recall was examined using different presentation conditions on 5 consecutive days. The presentation conditions significantly influenced recall performance depending on the diagnosis and on the delay of recall. Naming of pictures did not improve later …

Malemedicine.medical_specialtyTime FactorsCognitive NeuroscienceAudiologyDevelopmental psychologyAlzheimer DiseasemedicineHumansAgedCognitive reserveAged 80 and overForgettingRecallRepetition (rhetorical device)Recall testInspection timemedicine.diseaseForm PerceptionPsychiatry and Mental healthFree recallMental RecallFemaleGeriatrics and GerontologyAlzheimer's diseasePsychologyDementia and Geriatric Cognitive Disorders
researchProduct

IMPROVEMENT OF PICTURE RECALL BY REPETITION IN PATIENTS WITH DEMENTIA OF ALZHEIMER TYPE

1997

The evidence for positive effects of repetition on recall performance in patients with dementia of Alzheimer type is equivocal. This may be due to the difference repetition conditions used. The aim of this study was therefore to evaluate the effects of different repetition modes on the improvement of recall performance in demented subjects. Twenty-four patients with Alzheimer type dementia and 24 control subjects with remitted depression were included in the study. Pictures were presented repeatedly using different presentation modes at a constant total presentation time. Free recall was tested repeatedly after different periods of delay (0-8 hours). Immediate and delayed list repetition si…

Malemedicine.medical_specialtyTime FactorsNeuropsychological TestsAudiologySensitivity and SpecificityDevelopmental psychologyAlzheimer DiseaseMemorymedicineHumansLearningIn patientMemory disorderGeriatric AssessmentAgedRecognition memoryPsychiatric Status Rating ScalesDepressive DisorderRecallRepetition (rhetorical device)Cognitive disordermedicine.diseasePsychiatry and Mental healthFree recallCase-Control StudiesFemaleGeriatrics and GerontologyAlzheimer's diseasePsychologyInternational Journal of Geriatric Psychiatry
researchProduct

Transcranial Doppler sonography in dementia of Alzheimer type.

1994

The intention of this study was to examine the relation of clinical variables and cognitive dysfunction to cerebrovascular blood flow in a sample of patients with Alzheimer''s disease without any sign or symptom of cardiovascular or cerebrovascular disease. The patients met DSM-III-R criteria for dementia of Alzheimer type. Blood flow velocities in the anterior, middle (MCA) and posterior cerebral arteries were recorded using transcranial Doppler sonography. Several psychometric tests including the Mini-Mental State Examination (MMSE) were performed. The patients’ age correlated significantly with the systolic flow velocity in the left MCA (r = –0.57) explaining 24% of the total variance; t…

Malemedicine.medical_specialtyUltrasonography Doppler TranscranialCognitive NeuroscienceDiseaseNeuropsychological TestsCentral nervous system diseaseDegenerative diseaseAlzheimer DiseaseInternal medicinemedicineHumansAgedAged 80 and overbusiness.industryTranscranial doppler sonographyCognitionBlood flowMiddle Agedmedicine.diseaseSurgeryPsychiatry and Mental healthCerebral blood flowCerebrovascular CirculationCardiologyFemaleGeriatrics and GerontologyAlzheimer's diseasebusinessDementia (Basel, Switzerland)
researchProduct

Differential diagnosis of behavioral variant of fronto-temporal dementia (bvFTD)

2011

Background: The aim of the paper is the differential diagnosis of various types of Fronto-Temporal Dementia (FTD), with the focus on its behavioural variant (bvFTD). Material/Method: Material and Method. Screening was done in order to assess the depth of dementia with the short version of MMSE, while evaluation of various variants of FTD was performed with the use of such neuropsychological tests as Newcomb and Chicago Fluency Tests, Wechsler Memory Scale - III (WMS-III), Western Aphasia Battery (WAB-R), and the Boston Naming Test (BNT). Behaviour was evaluated with a Polish version of the Frontal Behavioral Inventory (FBInv). The inventory consists of 24 questions which enable an evaluatio…

Malemedicine.medical_specialtyexecutive functions disordersgenetic structuresdisinhibitionFronto temporal dementiabehavioral disciplines and activitiesDiagnosis DifferentialCognitionClinical ResearchAlzheimer DiseaseMemorymental disordersmedicineHumansDementiafrontal cortex dysfunctionsPsychiatryAgedDemographyLanguageIntelligence TestsBehaviornutritional and metabolic diseasesCognitionGeneral Medicinemedicine.diseasenervous system diseasesimpairments of cognitive functionsFrontotemporal DementiaFemaleAlzheimer's diseaseDifferential diagnosisPsychologyNeuroscienceFrontotemporal dementiaMedical Science Monitor
researchProduct